Proactive Investors - Run By Investors For Investors

Flowr Corp’s medical cannabis available to patients online at Shoppers Drug Mart

Co-CEO Vinay Tolia says the relationship shows the company's commitment to 'ultra-high-quality' cannabis cultivation and solidifies Flowr’s role in Canada’s medical cannabis landscape
A cannabis facility
Toronto headquartered Flowr has a large production facility in Kelowna and will supply products to Shoppers Drug Mart's online medical cannabis site

The Flowr Corporation (TSX-V:FLWR) (OTC:FLWPF) announced Monday that its FlowrRx products are now available for purchase through Shoppers Drug Mart’s online medical cannabis site.

On January 9, the two companies confirmed a sales agreement. Under the pact, Shoppers Drug Mart will be the exclusive direct-to-patient online provider of FlowrRx products. Previously, FlowrRx products were available online to patients registered via Flowr’s website.

READ: Harvest One to supply medical cannabis to Shoppers Drug Mart

Shares in the Toronto-headquartered company climbed nearly 1% to US$5.21 in the OTC Markets, while they were up 1.8% to C$6.94 in Canada. 

The company said the relationship with Shoppers Drug Mart represents a "milestone in the de-stigmatization of medical cannabis."

Shoppers Drug Mart bills itself as the first Canadian retail pharmacy chain to offer a variety of cannabis products to medical cannabis patients, but while product information is available nationally, it can initially only sell medical cannabis to patients in Ontario, through its site.

“We’re pleased to provide patients with the high quality and consistent products they seek, now with access to the world class patient care team that Shoppers Drug Mart has assembled,” said Flowr Corp co-CEO Vinay Tolia. “Flowr’s premium medical cannabis is grown in what we believe is the industry’s most advanced Good Manufacturing Practice (GMP)-designed cultivation facility. This relationship is testament to our commitment to ultra-high-quality cannabis cultivation and further solidifies Flowr’s role in Canada’s medical cannabis landscape.”

To order, patients must submit a completed medical document from a healthcare practitioner to Shoppers Drug Mart directly to begin the process.

Medical documents can be dropped off at Shoppers Drug Mart pharmacies in Ontario, provided by mail, or directly by a healthcare practitioner via secure fax.

Specialized advisers from the “Shoppers Cannabis Care team” will then contact the patients, review their medical history, and provide support with online registration and product selection.

Flowr through its subsidiaries, holds a cannabis production and sales licence granted by Health Canada. Headquartered in Toronto with a production facility in Kelowna, British Columbia, Flowr builds and operates large-scale, cultivation facilities utilizing its own patented growing systems. When fully completed, Flowr’s Kelowna campus is expected to produce over 50,000 kg of premium flower annually.

Flowr is expanding globally in Portugal and Australia, and recently broke ground on a 50,000 square feet R&D facility in partnership with Hawthorne, a subsidiary of Scotts Miracle Gro.

—(Story updated with stock price)—

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full FLWR profile View Profile

The Flowr Corporation Timeline

Related Articles

A WeedMD greenhouse
January 21 2019
WeedMD produces cannabis and cannabis oil for both the medical and adult-use markets
cannabis leaf
May 08 2019
The company plans to leverage its portfolio of brands as well as its distribution network of more than 39,000 European pharmacies to maximize margins and profitability
May 13 2019
1933 Industries is progressing with plans to launch one of Nevada's largest hemp extraction facilities, amidst a flurry of other activity
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use